Механизмы реализации сигнальной трансдукции

1. Владимирская Е.Б. Механизмы кроветворения и лейкемогенеза (цикл лекций). М.: Династия, 2007.

2. Копнин Б.П. Мишени действия онкогенов и опухолевых супрессоров: ключ к пониманию базовых механизмов канцерогенеза. Биохимия 2000;65:5–33.

3. Копнин Б.П. Механизмы действия онкогенов и опухолевых супрессоров, 2002 (есть несколько электронных версий этого обзора, см., например: http://longevitylibrary. narod.ru/1/1.1/1.1.21.htm).

4. Scott J., Pawson T. Cell signaling in space and time: where proteins come together and when they’re apart. Science 2009;326:1220–4.

5. Lodish H., Berk A., Matsudaira P. et al. Molecular cell biology. UK, Freeman & Co, 5 ed., 2004.

6. Ferrando A. The role of Notch1 signaling in T-ALL. Hematology 2009:353–61.

7. Citri A., Yarden Y. EGF-ERBB signalling: towards the systems level. Nat Rev Mol Cell Biol 2006;7:505–16.

8. Taniguchi C., Emanuelli B., Kahn R. Critical nodes in signalling pathways: insights into insulin action. Nat Rev Mol Cell Biol 2006;7:85–96.

9. Peisajovich S., Garbarino J., Wie P., Lim W. Rapid diversification of cell signaling phenotypes by modular domain recombination. Science 2010;328:368–72.

10. Pryciak P. Designing new cellular signaling pathways. Chem Biol 2009;16:249–54.

11. Lim W. Designing customized cell signalling circuits. Nat Rev Mol Cell Biol 2010;11:293–403.

12. Blume-Jensen P., Hunter T. Oncogenic kinase signalling. Nature 2001;411:355–65.

13. Lemmon M., Schlessinger J. Cell signaling by receptor tyrosine kinases. Cell 2010;141:1117–34.

14. Hubbard S. Juxtamembrane autoinhibition in receptor tyrosine kinases. Nat Rev Mol Cell Biol 2004;5:464–71.

15. Swanson C., Paniagua R., Lindstrom T., Robinson W. Tyrosine kinases as targets for the treatment of rheumatoid arthritis. Nat Rev Rheumatology 2009;5:317–24.

16. Le Roy C., Wrana J. Clathrin- and non-clathrin-mediated endocytic regulation of cell signalling. Nat Rev Mol Cell Biol 2005;6:112–26.

17. Sorkin A., von Zastrow M. Endocytosis and signalling: intertwining molecular networks. Nat Rev Mol Cell Biol 2009;10:609–22.

18. Wang Y-N., Yamaguchi H., Hsu J-M., Hung M-C. Nuclear trafficking of the epidermal growth factor receptor family membrane proteins. Oncogene 2010;29:3997–4006.

19. Rozengurt E. Mitogenic signaling pathways induced by G protein-coupled receptors. J Cell Physiol 2007;213:589–602.

20. Hancock J. Ras proteins: different signals from different locations. Nat Rev Mol Cell Biol 2003;4:373–85.

21. Schubbert S., Shannon K., Bollag G. Hyperactive Ras in developmental disorders and cancer. Nat Rev Cancer 2007;7:295–308.

22. Mardilovich K., Pankratz S., Shaw L. Expression and function of the insulin receptor substrate proteins in cancer. Cell Comm Signaling 2009;7:14–28.

23. Bhaskar P., Hay N. The two TORCs and Akt. Develop Cell 2007;12:487–502.

24. Simons K., Toomre D. Lipid rafts and signal transduction. Nat Rev Mol Cell Biol 2000;1:31–9.

25. Wymann M., Schneiter R. Lipid signalling in disease. Nat Rev Mol Cell Biol 2008; 9:162–76.

26. Groves J., Kuriyan J. Molecular mechanisms in signal transduction at the membrane. Nat Structur Mol Biol 2010;17:659–65.

27. Kurosaki T. Regulation of B-cell signal ransduction by adaptor proteins. Nat Rev Immunol 2002;2:354–63.

28. Seet B., Dikic I., Zhou M., Pawson T. Reading protein modifications with interaction domains. Nat Rev Mol Cell Biol 2006;7:473–83 (см. также постер этих авторов — http://www.nature.com/nrm/posters/modifications/nrm0706-poster-web.pdf).

29. Buday L., Tompa P. Functional classification of scaffold proteins and related molecules. FEBS J 2010;277:4348–55.

30. Welchman R., Gordon C., Mayer J. Ubiquitin and ubiquitin-like proteins as multifunctional signals. Nat Rev Mol Cell Biol 2005;6:599–609.

31. Hoeller D., Hecker C-M., Dikic I. Ubiquitin and ubiquitin-like proteins in cancer pathogenesis. Nat Rev Cancer 2006;6:776–88.

32. Chen Z., Sun L. Nonproteolytic functions of ubiquitin in cell signaling. Mol Cell 2009;33:275–86.